Showing results (111-120 of 317) with videos related to

Sort By:
Pageof 32
Critical Reviews in Oncology/Hematology|March 23, 2017
CDK4/6 inhibitors in HER2-positive breast cancerSilvia Paola Corona, Andrea Ravelli, Daniele Cretella, et al.
Seminars in Oncology|September 6, 2023
Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?Antonella Ferro, Daniele Generali, Orazio Caffo, et al.
Scientific Reports|September 12, 2019
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cellsDaniele Cretella, Claudia Fumarola, Mara Bonelli, et al.
Oncotarget|June 2, 2018
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancerGiandomenico Roviello, Silvia Paola Corona, Andrea Giovanni Multari, et al.
ESMO Open|December 19, 2018
Management of young women with early breast cancerFrancesca Poggio, Matteo Lambertini, Claudia Bighin, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2016
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trialsGiandomenico Roviello, Sandra Sigala, Shahneen Sandhu, et al.
Plos One|August 6, 2019
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinomaAlberto D'Angelo, Navid Sobhani, Giandomenico Roviello, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2015
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trialMatteo Lambertini, Paolo Bruzzi, Francesca Poggio, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 15, 2015
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectivesGiandomenico Roviello, Karol Polom, Roberto Petrioli, et al.
Current Issues in Molecular Biology|September 22, 2022
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity StudyAlberto D'Angelo, Fabiola Giudici, Robert Chapman, et al.
Pageof 32